Covid-19 Impact on Global Isoflurane Market Insights, Forecast to 2026
Isoflurane, sold under the trade name Forane among others, is a general anesthetic?It can be used to start or maintain anesthesia.[1] Often another medication is used to start anesthesia due to airway irritation with isoflurane.It is used by inhalation.Side effects include a decreased ability to breathe (respiratory depression), low blood pressure, and irregular heartbeat. Serious side effects may include malignant hyperthermia and high blood potassium.It should not be used in people with a history of malignant hyperthermia in either themselves or their family members.It is unknown if use during pregnancy is safe for the baby, but use during a cesarean section appears to be safe.Isoflurane is in the halogenated ether family of medication.Isoflurane was approved for medical use in the United States in 1979. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Isoflurane market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Isoflurane industry.
Based on our recent survey, we have several different scenarios about the Isoflurane YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Isoflurane will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Isoflurane market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Isoflurane market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Isoflurane market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Isoflurane market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Isoflurane market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Isoflurane market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Isoflurane market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Isoflurane market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Isoflurane market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Isoflurane industry.
Based on our recent survey, we have several different scenarios about the Isoflurane YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Isoflurane will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Isoflurane market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Isoflurane market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Isoflurane market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Isoflurane market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Isoflurane market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Isoflurane market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Isoflurane market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Isoflurane market.
The following manufacturers are covered in this report:
- Piramal Critical Care(Piramal Group)
- Halocarbon
- Aesica(Consort Medical Group)
- Lunan Pharmaceutical Group
- Shandong Keyuan Pharmaceutical Co., Ltd.
- Pfizer
- Indofine Chemical Company, Inc.
- Medicon Lifesciences
- Rewine Pharmaceutical
- Human Series
- Animal Series
- Hospitals
- Other Medical Institutions
1 STUDY COVERAGE
1.1 Isoflurane Product Introduction
1.2 Market Segments
1.3 Key Isoflurane Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Isoflurane Market Size Growth Rate by Type
1.4.2 Human Series
1.4.3 Animal Series
1.5 Market by Application
1.5.1 Global Isoflurane Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Other Medical Institutions
1.6 Coronavirus Disease 2019 (Covid-19): Isoflurane Industry Impact
1.6.1 How the Covid-19 is Affecting the Isoflurane Industry
1.6.1.1 Isoflurane Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Isoflurane Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Isoflurane Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Isoflurane Market Size Estimates and Forecasts
2.1.1 Global Isoflurane Revenue 2015-2026
2.1.2 Global Isoflurane Sales 2015-2026
2.2 Isoflurane Market Size by Region: 2020 Versus 2026
2.2.1 Global Isoflurane Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Isoflurane Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ISOFLURANE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Isoflurane Sales by Manufacturers
3.1.1 Isoflurane Sales by Manufacturers (2015-2020)
3.1.2 Isoflurane Sales Market Share by Manufacturers (2015-2020)
3.2 Isoflurane Revenue by Manufacturers
3.2.1 Isoflurane Revenue by Manufacturers (2015-2020)
3.2.2 Isoflurane Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Isoflurane Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Isoflurane Revenue in 2019
3.2.5 Global Isoflurane Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Isoflurane Price by Manufacturers
3.4 Isoflurane Manufacturing Base Distribution, Product Types
3.4.1 Isoflurane Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Isoflurane Product Type
3.4.3 Date of International Manufacturers Enter into Isoflurane Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Isoflurane Market Size by Type (2015-2020)
4.1.1 Global Isoflurane Sales by Type (2015-2020)
4.1.2 Global Isoflurane Revenue by Type (2015-2020)
4.1.3 Isoflurane Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Isoflurane Market Size Forecast by Type (2021-2026)
4.2.1 Global Isoflurane Sales Forecast by Type (2021-2026)
4.2.2 Global Isoflurane Revenue Forecast by Type (2021-2026)
4.2.3 Isoflurane Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Isoflurane Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Isoflurane Market Size by Application (2015-2020)
5.1.1 Global Isoflurane Sales by Application (2015-2020)
5.1.2 Global Isoflurane Revenue by Application (2015-2020)
5.1.3 Isoflurane Price by Application (2015-2020)
5.2 Isoflurane Market Size Forecast by Application (2021-2026)
5.2.1 Global Isoflurane Sales Forecast by Application (2021-2026)
5.2.2 Global Isoflurane Revenue Forecast by Application (2021-2026)
5.2.3 Global Isoflurane Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Isoflurane by Country
6.1.1 North America Isoflurane Sales by Country
6.1.2 North America Isoflurane Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Isoflurane Market Facts & Figures by Type
6.3 North America Isoflurane Market Facts & Figures by Application
7 EUROPE
7.1 Europe Isoflurane by Country
7.1.1 Europe Isoflurane Sales by Country
7.1.2 Europe Isoflurane Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Isoflurane Market Facts & Figures by Type
7.3 Europe Isoflurane Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Isoflurane by Region
8.1.1 Asia Pacific Isoflurane Sales by Region
8.1.2 Asia Pacific Isoflurane Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Isoflurane Market Facts & Figures by Type
8.3 Asia Pacific Isoflurane Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Isoflurane by Country
9.1.1 Latin America Isoflurane Sales by Country
9.1.2 Latin America Isoflurane Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Isoflurane Market Facts & Figures by Type
9.3 Central & South America Isoflurane Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Isoflurane by Country
10.1.1 Middle East and Africa Isoflurane Sales by Country
10.1.2 Middle East and Africa Isoflurane Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Isoflurane Market Facts & Figures by Type
10.3 Middle East and Africa Isoflurane Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Piramal Critical Care(Piramal Group)
11.1.1 Piramal Critical Care(Piramal Group) Corporation Information
11.1.2 Piramal Critical Care(Piramal Group) Description, Business Overview and Total Revenue
11.1.3 Piramal Critical Care(Piramal Group) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Piramal Critical Care(Piramal Group) Isoflurane Products Offered
11.1.5 Piramal Critical Care(Piramal Group) Recent Development
11.2 Halocarbon
11.2.1 Halocarbon Corporation Information
11.2.2 Halocarbon Description, Business Overview and Total Revenue
11.2.3 Halocarbon Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Halocarbon Isoflurane Products Offered
11.2.5 Halocarbon Recent Development
11.3 Aesica(Consort Medical Group)
11.3.1 Aesica(Consort Medical Group) Corporation Information
11.3.2 Aesica(Consort Medical Group) Description, Business Overview and Total Revenue
11.3.3 Aesica(Consort Medical Group) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aesica(Consort Medical Group) Isoflurane Products Offered
11.3.5 Aesica(Consort Medical Group) Recent Development
11.4 Lunan Pharmaceutical Group
11.4.1 Lunan Pharmaceutical Group Corporation Information
11.4.2 Lunan Pharmaceutical Group Description, Business Overview and Total Revenue
11.4.3 Lunan Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lunan Pharmaceutical Group Isoflurane Products Offered
11.4.5 Lunan Pharmaceutical Group Recent Development
11.5 Shandong Keyuan Pharmaceutical Co., Ltd.
11.5.1 Shandong Keyuan Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Shandong Keyuan Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue
11.5.3 Shandong Keyuan Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Products Offered
11.5.5 Shandong Keyuan Pharmaceutical Co., Ltd. Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Isoflurane Products Offered
11.6.5 Pfizer Recent Development
11.7 Indofine Chemical Company, Inc.
11.7.1 Indofine Chemical Company, Inc. Corporation Information
11.7.2 Indofine Chemical Company, Inc. Description, Business Overview and Total Revenue
11.7.3 Indofine Chemical Company, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Indofine Chemical Company, Inc. Isoflurane Products Offered
11.7.5 Indofine Chemical Company, Inc. Recent Development
11.8 Medicon Lifesciences
11.8.1 Medicon Lifesciences Corporation Information
11.8.2 Medicon Lifesciences Description, Business Overview and Total Revenue
11.8.3 Medicon Lifesciences Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Medicon Lifesciences Isoflurane Products Offered
11.8.5 Medicon Lifesciences Recent Development
11.9 Rewine Pharmaceutical
11.9.1 Rewine Pharmaceutical Corporation Information
11.9.2 Rewine Pharmaceutical Description, Business Overview and Total Revenue
11.9.3 Rewine Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Rewine Pharmaceutical Isoflurane Products Offered
11.9.5 Rewine Pharmaceutical Recent Development
11.1 Piramal Critical Care(Piramal Group)
11.1.1 Piramal Critical Care(Piramal Group) Corporation Information
11.1.2 Piramal Critical Care(Piramal Group) Description, Business Overview and Total Revenue
11.1.3 Piramal Critical Care(Piramal Group) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Piramal Critical Care(Piramal Group) Isoflurane Products Offered
11.1.5 Piramal Critical Care(Piramal Group) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Isoflurane Market Estimates and Projections by Region
12.1.1 Global Isoflurane Sales Forecast by Regions 2021-2026
12.1.2 Global Isoflurane Revenue Forecast by Regions 2021-2026
12.2 North America Isoflurane Market Size Forecast (2021-2026)
12.2.1 North America: Isoflurane Sales Forecast (2021-2026)
12.2.2 North America: Isoflurane Revenue Forecast (2021-2026)
12.2.3 North America: Isoflurane Market Size Forecast by Country (2021-2026)
12.3 Europe Isoflurane Market Size Forecast (2021-2026)
12.3.1 Europe: Isoflurane Sales Forecast (2021-2026)
12.3.2 Europe: Isoflurane Revenue Forecast (2021-2026)
12.3.3 Europe: Isoflurane Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Isoflurane Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Isoflurane Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Isoflurane Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Isoflurane Market Size Forecast by Region (2021-2026)
12.5 Latin America Isoflurane Market Size Forecast (2021-2026)
12.5.1 Latin America: Isoflurane Sales Forecast (2021-2026)
12.5.2 Latin America: Isoflurane Revenue Forecast (2021-2026)
12.5.3 Latin America: Isoflurane Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Isoflurane Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Isoflurane Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Isoflurane Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Isoflurane Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Isoflurane Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Isoflurane Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Isoflurane Product Introduction
1.2 Market Segments
1.3 Key Isoflurane Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Isoflurane Market Size Growth Rate by Type
1.4.2 Human Series
1.4.3 Animal Series
1.5 Market by Application
1.5.1 Global Isoflurane Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Other Medical Institutions
1.6 Coronavirus Disease 2019 (Covid-19): Isoflurane Industry Impact
1.6.1 How the Covid-19 is Affecting the Isoflurane Industry
1.6.1.1 Isoflurane Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Isoflurane Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Isoflurane Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Isoflurane Market Size Estimates and Forecasts
2.1.1 Global Isoflurane Revenue 2015-2026
2.1.2 Global Isoflurane Sales 2015-2026
2.2 Isoflurane Market Size by Region: 2020 Versus 2026
2.2.1 Global Isoflurane Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Isoflurane Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ISOFLURANE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Isoflurane Sales by Manufacturers
3.1.1 Isoflurane Sales by Manufacturers (2015-2020)
3.1.2 Isoflurane Sales Market Share by Manufacturers (2015-2020)
3.2 Isoflurane Revenue by Manufacturers
3.2.1 Isoflurane Revenue by Manufacturers (2015-2020)
3.2.2 Isoflurane Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Isoflurane Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Isoflurane Revenue in 2019
3.2.5 Global Isoflurane Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Isoflurane Price by Manufacturers
3.4 Isoflurane Manufacturing Base Distribution, Product Types
3.4.1 Isoflurane Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Isoflurane Product Type
3.4.3 Date of International Manufacturers Enter into Isoflurane Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Isoflurane Market Size by Type (2015-2020)
4.1.1 Global Isoflurane Sales by Type (2015-2020)
4.1.2 Global Isoflurane Revenue by Type (2015-2020)
4.1.3 Isoflurane Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Isoflurane Market Size Forecast by Type (2021-2026)
4.2.1 Global Isoflurane Sales Forecast by Type (2021-2026)
4.2.2 Global Isoflurane Revenue Forecast by Type (2021-2026)
4.2.3 Isoflurane Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Isoflurane Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Isoflurane Market Size by Application (2015-2020)
5.1.1 Global Isoflurane Sales by Application (2015-2020)
5.1.2 Global Isoflurane Revenue by Application (2015-2020)
5.1.3 Isoflurane Price by Application (2015-2020)
5.2 Isoflurane Market Size Forecast by Application (2021-2026)
5.2.1 Global Isoflurane Sales Forecast by Application (2021-2026)
5.2.2 Global Isoflurane Revenue Forecast by Application (2021-2026)
5.2.3 Global Isoflurane Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Isoflurane by Country
6.1.1 North America Isoflurane Sales by Country
6.1.2 North America Isoflurane Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Isoflurane Market Facts & Figures by Type
6.3 North America Isoflurane Market Facts & Figures by Application
7 EUROPE
7.1 Europe Isoflurane by Country
7.1.1 Europe Isoflurane Sales by Country
7.1.2 Europe Isoflurane Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Isoflurane Market Facts & Figures by Type
7.3 Europe Isoflurane Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Isoflurane by Region
8.1.1 Asia Pacific Isoflurane Sales by Region
8.1.2 Asia Pacific Isoflurane Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Isoflurane Market Facts & Figures by Type
8.3 Asia Pacific Isoflurane Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Isoflurane by Country
9.1.1 Latin America Isoflurane Sales by Country
9.1.2 Latin America Isoflurane Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Isoflurane Market Facts & Figures by Type
9.3 Central & South America Isoflurane Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Isoflurane by Country
10.1.1 Middle East and Africa Isoflurane Sales by Country
10.1.2 Middle East and Africa Isoflurane Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Isoflurane Market Facts & Figures by Type
10.3 Middle East and Africa Isoflurane Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Piramal Critical Care(Piramal Group)
11.1.1 Piramal Critical Care(Piramal Group) Corporation Information
11.1.2 Piramal Critical Care(Piramal Group) Description, Business Overview and Total Revenue
11.1.3 Piramal Critical Care(Piramal Group) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Piramal Critical Care(Piramal Group) Isoflurane Products Offered
11.1.5 Piramal Critical Care(Piramal Group) Recent Development
11.2 Halocarbon
11.2.1 Halocarbon Corporation Information
11.2.2 Halocarbon Description, Business Overview and Total Revenue
11.2.3 Halocarbon Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Halocarbon Isoflurane Products Offered
11.2.5 Halocarbon Recent Development
11.3 Aesica(Consort Medical Group)
11.3.1 Aesica(Consort Medical Group) Corporation Information
11.3.2 Aesica(Consort Medical Group) Description, Business Overview and Total Revenue
11.3.3 Aesica(Consort Medical Group) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aesica(Consort Medical Group) Isoflurane Products Offered
11.3.5 Aesica(Consort Medical Group) Recent Development
11.4 Lunan Pharmaceutical Group
11.4.1 Lunan Pharmaceutical Group Corporation Information
11.4.2 Lunan Pharmaceutical Group Description, Business Overview and Total Revenue
11.4.3 Lunan Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lunan Pharmaceutical Group Isoflurane Products Offered
11.4.5 Lunan Pharmaceutical Group Recent Development
11.5 Shandong Keyuan Pharmaceutical Co., Ltd.
11.5.1 Shandong Keyuan Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Shandong Keyuan Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue
11.5.3 Shandong Keyuan Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Products Offered
11.5.5 Shandong Keyuan Pharmaceutical Co., Ltd. Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Isoflurane Products Offered
11.6.5 Pfizer Recent Development
11.7 Indofine Chemical Company, Inc.
11.7.1 Indofine Chemical Company, Inc. Corporation Information
11.7.2 Indofine Chemical Company, Inc. Description, Business Overview and Total Revenue
11.7.3 Indofine Chemical Company, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Indofine Chemical Company, Inc. Isoflurane Products Offered
11.7.5 Indofine Chemical Company, Inc. Recent Development
11.8 Medicon Lifesciences
11.8.1 Medicon Lifesciences Corporation Information
11.8.2 Medicon Lifesciences Description, Business Overview and Total Revenue
11.8.3 Medicon Lifesciences Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Medicon Lifesciences Isoflurane Products Offered
11.8.5 Medicon Lifesciences Recent Development
11.9 Rewine Pharmaceutical
11.9.1 Rewine Pharmaceutical Corporation Information
11.9.2 Rewine Pharmaceutical Description, Business Overview and Total Revenue
11.9.3 Rewine Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Rewine Pharmaceutical Isoflurane Products Offered
11.9.5 Rewine Pharmaceutical Recent Development
11.1 Piramal Critical Care(Piramal Group)
11.1.1 Piramal Critical Care(Piramal Group) Corporation Information
11.1.2 Piramal Critical Care(Piramal Group) Description, Business Overview and Total Revenue
11.1.3 Piramal Critical Care(Piramal Group) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Piramal Critical Care(Piramal Group) Isoflurane Products Offered
11.1.5 Piramal Critical Care(Piramal Group) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Isoflurane Market Estimates and Projections by Region
12.1.1 Global Isoflurane Sales Forecast by Regions 2021-2026
12.1.2 Global Isoflurane Revenue Forecast by Regions 2021-2026
12.2 North America Isoflurane Market Size Forecast (2021-2026)
12.2.1 North America: Isoflurane Sales Forecast (2021-2026)
12.2.2 North America: Isoflurane Revenue Forecast (2021-2026)
12.2.3 North America: Isoflurane Market Size Forecast by Country (2021-2026)
12.3 Europe Isoflurane Market Size Forecast (2021-2026)
12.3.1 Europe: Isoflurane Sales Forecast (2021-2026)
12.3.2 Europe: Isoflurane Revenue Forecast (2021-2026)
12.3.3 Europe: Isoflurane Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Isoflurane Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Isoflurane Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Isoflurane Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Isoflurane Market Size Forecast by Region (2021-2026)
12.5 Latin America Isoflurane Market Size Forecast (2021-2026)
12.5.1 Latin America: Isoflurane Sales Forecast (2021-2026)
12.5.2 Latin America: Isoflurane Revenue Forecast (2021-2026)
12.5.3 Latin America: Isoflurane Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Isoflurane Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Isoflurane Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Isoflurane Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Isoflurane Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Isoflurane Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Isoflurane Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Isoflurane Market Segments
Table 2. Ranking of Global Top Isoflurane Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Isoflurane Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Human Series
Table 5. Major Manufacturers of Animal Series
Table 6. COVID-19 Impact Global Market: (Four Isoflurane Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Isoflurane Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Isoflurane Players to Combat Covid-19 Impact
Table 11. Global Isoflurane Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Isoflurane Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Isoflurane Sales by Regions 2015-2020 (K MT)
Table 14. Global Isoflurane Sales Market Share by Regions (2015-2020)
Table 15. Global Isoflurane Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Isoflurane Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Isoflurane Sales Share by Manufacturers (2015-2020)
Table 18. Global Isoflurane Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Isoflurane by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isoflurane as of 2019)
Table 20. Isoflurane Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Isoflurane Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Isoflurane Price (2015-2020) (USD/MT)
Table 23. Isoflurane Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Isoflurane Product Type
Table 25. Date of International Manufacturers Enter into Isoflurane Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Isoflurane Sales by Type (2015-2020) (K MT)
Table 28. Global Isoflurane Sales Share by Type (2015-2020)
Table 29. Global Isoflurane Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Isoflurane Revenue Share by Type (2015-2020)
Table 31. Isoflurane Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Isoflurane Sales by Application (2015-2020) (K MT)
Table 33. Global Isoflurane Sales Share by Application (2015-2020)
Table 34. North America Isoflurane Sales by Country (2015-2020) (K MT)
Table 35. North America Isoflurane Sales Market Share by Country (2015-2020)
Table 36. North America Isoflurane Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Isoflurane Revenue Market Share by Country (2015-2020)
Table 38. North America Isoflurane Sales by Type (2015-2020) (K MT)
Table 39. North America Isoflurane Sales Market Share by Type (2015-2020)
Table 40. North America Isoflurane Sales by Application (2015-2020) (K MT)
Table 41. North America Isoflurane Sales Market Share by Application (2015-2020)
Table 42. Europe Isoflurane Sales by Country (2015-2020) (K MT)
Table 43. Europe Isoflurane Sales Market Share by Country (2015-2020)
Table 44. Europe Isoflurane Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Isoflurane Revenue Market Share by Country (2015-2020)
Table 46. Europe Isoflurane Sales by Type (2015-2020) (K MT)
Table 47. Europe Isoflurane Sales Market Share by Type (2015-2020)
Table 48. Europe Isoflurane Sales by Application (2015-2020) (K MT)
Table 49. Europe Isoflurane Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Isoflurane Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Isoflurane Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Isoflurane Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Isoflurane Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Isoflurane Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Isoflurane Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Isoflurane Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Isoflurane Sales Market Share by Application (2015-2020)
Table 58. Latin America Isoflurane Sales by Country (2015-2020) (K MT)
Table 59. Latin America Isoflurane Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Isoflurane Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Isoflurane Revenue Market Share by Country (2015-2020)
Table 62. Latin America Isoflurane Sales by Type (2015-2020) (K MT)
Table 63. Latin America Isoflurane Sales Market Share by Type (2015-2020)
Table 64. Latin America Isoflurane Sales by Application (2015-2020) (K MT)
Table 65. Latin America Isoflurane Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Isoflurane Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Isoflurane Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Isoflurane Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Isoflurane Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Isoflurane Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Isoflurane Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Isoflurane Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Isoflurane Sales Market Share by Application (2015-2020)
Table 74. Piramal Critical Care(Piramal Group) Corporation Information
Table 75. Piramal Critical Care(Piramal Group) Description and Major Businesses
Table 76. Piramal Critical Care(Piramal Group) Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Piramal Critical Care(Piramal Group) Product
Table 78. Piramal Critical Care(Piramal Group) Recent Development
Table 79. Halocarbon Corporation Information
Table 80. Halocarbon Description and Major Businesses
Table 81. Halocarbon Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Halocarbon Product
Table 83. Halocarbon Recent Development
Table 84. Aesica(Consort Medical Group) Corporation Information
Table 85. Aesica(Consort Medical Group) Description and Major Businesses
Table 86. Aesica(Consort Medical Group) Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Aesica(Consort Medical Group) Product
Table 88. Aesica(Consort Medical Group) Recent Development
Table 89. Lunan Pharmaceutical Group Corporation Information
Table 90. Lunan Pharmaceutical Group Description and Major Businesses
Table 91. Lunan Pharmaceutical Group Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Lunan Pharmaceutical Group Product
Table 93. Lunan Pharmaceutical Group Recent Development
Table 94. Shandong Keyuan Pharmaceutical Co., Ltd. Corporation Information
Table 95. Shandong Keyuan Pharmaceutical Co., Ltd. Description and Major Businesses
Table 96. Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Shandong Keyuan Pharmaceutical Co., Ltd. Product
Table 98. Shandong Keyuan Pharmaceutical Co., Ltd. Recent Development
Table 99. Pfizer Corporation Information
Table 100. Pfizer Description and Major Businesses
Table 101. Pfizer Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Pfizer Product
Table 103. Pfizer Recent Development
Table 104. Indofine Chemical Company, Inc. Corporation Information
Table 105. Indofine Chemical Company, Inc. Description and Major Businesses
Table 106. Indofine Chemical Company, Inc. Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Indofine Chemical Company, Inc. Product
Table 108. Indofine Chemical Company, Inc. Recent Development
Table 109. Medicon Lifesciences Corporation Information
Table 110. Medicon Lifesciences Description and Major Businesses
Table 111. Medicon Lifesciences Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Medicon Lifesciences Product
Table 113. Medicon Lifesciences Recent Development
Table 114. Rewine Pharmaceutical Corporation Information
Table 115. Rewine Pharmaceutical Description and Major Businesses
Table 116. Rewine Pharmaceutical Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Rewine Pharmaceutical Product
Table 118. Rewine Pharmaceutical Recent Development
Table 119. Global Isoflurane Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global Isoflurane Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Isoflurane Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Isoflurane Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Isoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: Isoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Isoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: Isoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Isoflurane Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: Isoflurane Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Isoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: Isoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Isoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: Isoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Isoflurane Players
Table 137. Isoflurane Customers List
Table 138. Isoflurane Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 1. Isoflurane Market Segments
Table 2. Ranking of Global Top Isoflurane Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Isoflurane Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Human Series
Table 5. Major Manufacturers of Animal Series
Table 6. COVID-19 Impact Global Market: (Four Isoflurane Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Isoflurane Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Isoflurane Players to Combat Covid-19 Impact
Table 11. Global Isoflurane Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Isoflurane Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Isoflurane Sales by Regions 2015-2020 (K MT)
Table 14. Global Isoflurane Sales Market Share by Regions (2015-2020)
Table 15. Global Isoflurane Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Isoflurane Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Isoflurane Sales Share by Manufacturers (2015-2020)
Table 18. Global Isoflurane Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Isoflurane by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isoflurane as of 2019)
Table 20. Isoflurane Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Isoflurane Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Isoflurane Price (2015-2020) (USD/MT)
Table 23. Isoflurane Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Isoflurane Product Type
Table 25. Date of International Manufacturers Enter into Isoflurane Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Isoflurane Sales by Type (2015-2020) (K MT)
Table 28. Global Isoflurane Sales Share by Type (2015-2020)
Table 29. Global Isoflurane Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Isoflurane Revenue Share by Type (2015-2020)
Table 31. Isoflurane Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Isoflurane Sales by Application (2015-2020) (K MT)
Table 33. Global Isoflurane Sales Share by Application (2015-2020)
Table 34. North America Isoflurane Sales by Country (2015-2020) (K MT)
Table 35. North America Isoflurane Sales Market Share by Country (2015-2020)
Table 36. North America Isoflurane Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Isoflurane Revenue Market Share by Country (2015-2020)
Table 38. North America Isoflurane Sales by Type (2015-2020) (K MT)
Table 39. North America Isoflurane Sales Market Share by Type (2015-2020)
Table 40. North America Isoflurane Sales by Application (2015-2020) (K MT)
Table 41. North America Isoflurane Sales Market Share by Application (2015-2020)
Table 42. Europe Isoflurane Sales by Country (2015-2020) (K MT)
Table 43. Europe Isoflurane Sales Market Share by Country (2015-2020)
Table 44. Europe Isoflurane Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Isoflurane Revenue Market Share by Country (2015-2020)
Table 46. Europe Isoflurane Sales by Type (2015-2020) (K MT)
Table 47. Europe Isoflurane Sales Market Share by Type (2015-2020)
Table 48. Europe Isoflurane Sales by Application (2015-2020) (K MT)
Table 49. Europe Isoflurane Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Isoflurane Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Isoflurane Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Isoflurane Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Isoflurane Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Isoflurane Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Isoflurane Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Isoflurane Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Isoflurane Sales Market Share by Application (2015-2020)
Table 58. Latin America Isoflurane Sales by Country (2015-2020) (K MT)
Table 59. Latin America Isoflurane Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Isoflurane Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Isoflurane Revenue Market Share by Country (2015-2020)
Table 62. Latin America Isoflurane Sales by Type (2015-2020) (K MT)
Table 63. Latin America Isoflurane Sales Market Share by Type (2015-2020)
Table 64. Latin America Isoflurane Sales by Application (2015-2020) (K MT)
Table 65. Latin America Isoflurane Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Isoflurane Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Isoflurane Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Isoflurane Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Isoflurane Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Isoflurane Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Isoflurane Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Isoflurane Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Isoflurane Sales Market Share by Application (2015-2020)
Table 74. Piramal Critical Care(Piramal Group) Corporation Information
Table 75. Piramal Critical Care(Piramal Group) Description and Major Businesses
Table 76. Piramal Critical Care(Piramal Group) Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Piramal Critical Care(Piramal Group) Product
Table 78. Piramal Critical Care(Piramal Group) Recent Development
Table 79. Halocarbon Corporation Information
Table 80. Halocarbon Description and Major Businesses
Table 81. Halocarbon Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Halocarbon Product
Table 83. Halocarbon Recent Development
Table 84. Aesica(Consort Medical Group) Corporation Information
Table 85. Aesica(Consort Medical Group) Description and Major Businesses
Table 86. Aesica(Consort Medical Group) Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Aesica(Consort Medical Group) Product
Table 88. Aesica(Consort Medical Group) Recent Development
Table 89. Lunan Pharmaceutical Group Corporation Information
Table 90. Lunan Pharmaceutical Group Description and Major Businesses
Table 91. Lunan Pharmaceutical Group Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Lunan Pharmaceutical Group Product
Table 93. Lunan Pharmaceutical Group Recent Development
Table 94. Shandong Keyuan Pharmaceutical Co., Ltd. Corporation Information
Table 95. Shandong Keyuan Pharmaceutical Co., Ltd. Description and Major Businesses
Table 96. Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Shandong Keyuan Pharmaceutical Co., Ltd. Product
Table 98. Shandong Keyuan Pharmaceutical Co., Ltd. Recent Development
Table 99. Pfizer Corporation Information
Table 100. Pfizer Description and Major Businesses
Table 101. Pfizer Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Pfizer Product
Table 103. Pfizer Recent Development
Table 104. Indofine Chemical Company, Inc. Corporation Information
Table 105. Indofine Chemical Company, Inc. Description and Major Businesses
Table 106. Indofine Chemical Company, Inc. Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Indofine Chemical Company, Inc. Product
Table 108. Indofine Chemical Company, Inc. Recent Development
Table 109. Medicon Lifesciences Corporation Information
Table 110. Medicon Lifesciences Description and Major Businesses
Table 111. Medicon Lifesciences Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Medicon Lifesciences Product
Table 113. Medicon Lifesciences Recent Development
Table 114. Rewine Pharmaceutical Corporation Information
Table 115. Rewine Pharmaceutical Description and Major Businesses
Table 116. Rewine Pharmaceutical Isoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Rewine Pharmaceutical Product
Table 118. Rewine Pharmaceutical Recent Development
Table 119. Global Isoflurane Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global Isoflurane Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Isoflurane Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Isoflurane Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Isoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: Isoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Isoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: Isoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Isoflurane Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: Isoflurane Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Isoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: Isoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Isoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: Isoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Isoflurane Players
Table 137. Isoflurane Customers List
Table 138. Isoflurane Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Isoflurane Product Picture
Figure 2. Global Isoflurane Sales Market Share by Type in 2020 & 2026
Figure 3. Human Series Product Picture
Figure 4. Animal Series Product Picture
Figure 5. Global Isoflurane Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Other Medical Institutions
Figure 8. Isoflurane Report Years Considered
Figure 9. Global Isoflurane Market Size 2015-2026 (US$ Million)
Figure 10. Global Isoflurane Sales 2015-2026 (K MT)
Figure 11. Global Isoflurane Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Isoflurane Sales Market Share by Region (2015-2020)
Figure 13. Global Isoflurane Sales Market Share by Region in 2019
Figure 14. Global Isoflurane Revenue Market Share by Region (2015-2020)
Figure 15. Global Isoflurane Revenue Market Share by Region in 2019
Figure 16. Global Isoflurane Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Isoflurane Revenue in 2019
Figure 18. Isoflurane Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Isoflurane Sales Market Share by Type (2015-2020)
Figure 20. Global Isoflurane Sales Market Share by Type in 2019
Figure 21. Global Isoflurane Revenue Market Share by Type (2015-2020)
Figure 22. Global Isoflurane Revenue Market Share by Type in 2019
Figure 23. Global Isoflurane Market Share by Price Range (2015-2020)
Figure 24. Global Isoflurane Sales Market Share by Application (2015-2020)
Figure 25. Global Isoflurane Sales Market Share by Application in 2019
Figure 26. Global Isoflurane Revenue Market Share by Application (2015-2020)
Figure 27. Global Isoflurane Revenue Market Share by Application in 2019
Figure 28. North America Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Isoflurane Sales Market Share by Country in 2019
Figure 31. North America Isoflurane Revenue Market Share by Country in 2019
Figure 32. U.S. Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Isoflurane Market Share by Type in 2019
Figure 37. North America Isoflurane Market Share by Application in 2019
Figure 38. Europe Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Isoflurane Sales Market Share by Country in 2019
Figure 41. Europe Isoflurane Revenue Market Share by Country in 2019
Figure 42. Germany Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Isoflurane Market Share by Type in 2019
Figure 53. Europe Isoflurane Market Share by Application in 2019
Figure 54. Asia Pacific Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Isoflurane Sales Market Share by Region in 2019
Figure 57. Asia Pacific Isoflurane Revenue Market Share by Region in 2019
Figure 58. China Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Isoflurane Market Share by Type in 2019
Figure 81. Asia Pacific Isoflurane Market Share by Application in 2019
Figure 82. Latin America Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Isoflurane Sales Market Share by Country in 2019
Figure 85. Latin America Isoflurane Revenue Market Share by Country in 2019
Figure 86. Mexico Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Isoflurane Market Share by Type in 2019
Figure 93. Latin America Isoflurane Market Share by Application in 2019
Figure 94. Middle East and Africa Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Isoflurane Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Isoflurane Revenue Market Share by Country in 2019
Figure 98. Turkey Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Isoflurane Market Share by Type in 2019
Figure 105. Middle East and Africa Isoflurane Market Share by Application in 2019
Figure 106. Piramal Critical Care(Piramal Group) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Halocarbon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Aesica(Consort Medical Group) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Lunan Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Shandong Keyuan Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Indofine Chemical Company, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Medicon Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Rewine Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. North America Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Europe Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Asia Pacific Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Latin America Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Middle East and Africa Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
Figure 1. Isoflurane Product Picture
Figure 2. Global Isoflurane Sales Market Share by Type in 2020 & 2026
Figure 3. Human Series Product Picture
Figure 4. Animal Series Product Picture
Figure 5. Global Isoflurane Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Other Medical Institutions
Figure 8. Isoflurane Report Years Considered
Figure 9. Global Isoflurane Market Size 2015-2026 (US$ Million)
Figure 10. Global Isoflurane Sales 2015-2026 (K MT)
Figure 11. Global Isoflurane Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Isoflurane Sales Market Share by Region (2015-2020)
Figure 13. Global Isoflurane Sales Market Share by Region in 2019
Figure 14. Global Isoflurane Revenue Market Share by Region (2015-2020)
Figure 15. Global Isoflurane Revenue Market Share by Region in 2019
Figure 16. Global Isoflurane Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Isoflurane Revenue in 2019
Figure 18. Isoflurane Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Isoflurane Sales Market Share by Type (2015-2020)
Figure 20. Global Isoflurane Sales Market Share by Type in 2019
Figure 21. Global Isoflurane Revenue Market Share by Type (2015-2020)
Figure 22. Global Isoflurane Revenue Market Share by Type in 2019
Figure 23. Global Isoflurane Market Share by Price Range (2015-2020)
Figure 24. Global Isoflurane Sales Market Share by Application (2015-2020)
Figure 25. Global Isoflurane Sales Market Share by Application in 2019
Figure 26. Global Isoflurane Revenue Market Share by Application (2015-2020)
Figure 27. Global Isoflurane Revenue Market Share by Application in 2019
Figure 28. North America Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Isoflurane Sales Market Share by Country in 2019
Figure 31. North America Isoflurane Revenue Market Share by Country in 2019
Figure 32. U.S. Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Isoflurane Market Share by Type in 2019
Figure 37. North America Isoflurane Market Share by Application in 2019
Figure 38. Europe Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Isoflurane Sales Market Share by Country in 2019
Figure 41. Europe Isoflurane Revenue Market Share by Country in 2019
Figure 42. Germany Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Isoflurane Market Share by Type in 2019
Figure 53. Europe Isoflurane Market Share by Application in 2019
Figure 54. Asia Pacific Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Isoflurane Sales Market Share by Region in 2019
Figure 57. Asia Pacific Isoflurane Revenue Market Share by Region in 2019
Figure 58. China Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Isoflurane Market Share by Type in 2019
Figure 81. Asia Pacific Isoflurane Market Share by Application in 2019
Figure 82. Latin America Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Isoflurane Sales Market Share by Country in 2019
Figure 85. Latin America Isoflurane Revenue Market Share by Country in 2019
Figure 86. Mexico Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Isoflurane Market Share by Type in 2019
Figure 93. Latin America Isoflurane Market Share by Application in 2019
Figure 94. Middle East and Africa Isoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Isoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Isoflurane Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Isoflurane Revenue Market Share by Country in 2019
Figure 98. Turkey Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Isoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Isoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Isoflurane Market Share by Type in 2019
Figure 105. Middle East and Africa Isoflurane Market Share by Application in 2019
Figure 106. Piramal Critical Care(Piramal Group) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Halocarbon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Aesica(Consort Medical Group) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Lunan Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Shandong Keyuan Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Indofine Chemical Company, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Medicon Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Rewine Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. North America Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Europe Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Asia Pacific Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Latin America Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Isoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Middle East and Africa Isoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
